Welcome to CDC stacks | Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination - 21526 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
  • Published Date:
    Jan 2014
  • Source:
    Emerg Infect Dis. 20(1):142-145.
Filetype[PDF-365.66 KB]


Details:
No Related Documents.
You May Also Like:
  1. Human papilloma virus vaccination and incidence of ocular surface squamous neoplasia
    Personal Author:
    Carroll, Joy N.; Willis, Zachary I.; de St Maurice, Annabelle; Kohanim, Sahar;
    Published:
    2017
    Source:
    Int Ophthalmol Clin. 57(1):57-74.
    File Type:
    Filetype[PDF - 103.07 KB]
  2. Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States
    Personal Author:
    Stokley, Shannon; Curtis, C. Robinette; Jeyarajah, Jenny; Harrington, Theresa; Gee, Julianne; Markowitz, Lauri;
    Published:
    Jul 26 2013
    Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(29):591-595.
    Description:
    Since mid-2006, the Advisory Committee on Immunization Practices (ACIP) has recommended routine vaccination of adolescent girls at ages 11 or 12 years with 3 doses of human papillomavirus (HPV) vaccine. Two HPV vaccines are currently available in the...
    File Type:
    Filetype[PDF - 206.36 KB]
  3. CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease
    Personal Author:
    Dunne, Eileen F.; Markowitz, Lauri E.; Saraiya, Mona; Stokley, Shannon; Middleman, Amy; Unger, Elizabeth R.; Williams, Alcia; Iskander, John;
    Published:
    Jan 31 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(4):69-72.
    Description:
    Human papillomavirus (HPV) infection is the most common sexually transmitted infection in men and women in the United States. Most sexually active persons will acquire HPV in their lifetime. Recent data indicate that approximately 79 million persons ...
    File Type:
    Filetype[PDF - 241.90 KB]
  4. Model for Assessing Human Papillomavirus Vaccination Strategies
    Personal Author:
    Elbasha, Elamin H.; Dasbach, Erik J.; Insinga, Ralph P.;
    Published:
    Jan 2007
    Source:
    Emerg Infect Dis. 13(1):28-41.
    Description:
    We present a transmission dynamic model that can assess the epidemiologic consequences and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (types 6/11/16/18) human papillomavirus (HPV) vaccine in a setting of...
    File Type:
    Filetype[PDF - 651.55 KB]
  5. Human papillomavirus vaccination : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Markowitz, Lauri E.; Dunne, Eileen F.; Saraiya, Mona; Chesson, Harrell W.; Curtis, C. Robinette; Gee, Julianne; Bocchini, Joseph A.; Unger, Elizabeth R., 1951-;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.;
    Published:
    August 29, 2014
    Source:
    MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 63, RR-05
    Description:
    This report summarizes the epidemiology of human papillomavirus (HPV) and associated diseases, describes the licensed HPV vaccines, provides updated data from clinical trials and postlicensure safety studies, and compiles recommendations from CDC's A...
    Status:
    current
    File Type:
    Filetype[PDF - 757.82 KB]